Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy.
Kaneko G, Shirotake S, Nishimoto K, Miyazaki Y, Ito K, Ito Y, Hagiwara M, Kanao K, Nakagawa K, Momma T, Asano T, Tanaka N, Mizuno R, Oya M, Oyama M.
Kaneko G, et al.
Jpn J Clin Oncol. 2019 Aug 1;49(8):780-785. doi: 10.1093/jjco/hyz067.
Jpn J Clin Oncol. 2019.
PMID: 31063191